XEROQUEL LP 300 mg, extended-release tablet 30 tablets
Brand page: Xeroquel (quetiapine) — all forms and strengths in France
Active ingredients: Quetiapine, Quetiapine fumarate
Commercialized according to BDPMDispensing in France: Prescription only
Extended-release tablet30 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- XEROQUEL LP 300 mg, comprimé à libération prolongée
- Pharmaceutical form
- comprimé à libération prolongée
- Route of administration
- orale
- Presentation description
- plaquette(s) thermoformée(s) polychlortrifluoroéthylène PVC aluminium de 30 comprimé(s)
- Marketing authorisation holder
- DIFARMED (ESPAGNE)
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 19 May 2022
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
65781988CIP74900202CIP133400949002023Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| QUÉTIAPINE (FUMARATE DE)comprimé | — | SA |
| QUÉTIAPINEcomprimé | 300 mg · un comprimé | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.